Patents by Inventor Salvatore Troisi

Salvatore Troisi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Coloring substance for diagnostic ophtalmologic use
    Patent number: 9370587
    Abstract: The present invention relates to a substance selected from the group consisting of riboflavin, its esters, salts and hydrates thereof, for use in an ophthalmic diagnostic method. In preferred aspects of the invention, the riboflavin is applied into the eye as part of a solution having a concentration from about 0.01 and 0.5% riboflavin or acceptable salt, ester, hydrate thereof.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: June 21, 2016
    Assignees: IROS R.C. S.R.L
    Inventors: Ciro Caruso, Salvatore Troisi
  • Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
    Patent number: 9192594
    Abstract: An ophthalmic solution containing riboflavin and at least a compound chosen in the group composed of essential and conditionally essential amino acids, coenzyme Q, L-proline, glycine, lysine hydrochloride, L-leucine, L-arginine and compounds intended to stimulate the production of metalloproteinase MMP9 for the protection of internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: November 24, 2015
    Inventors: Salvatore Troisi, Antonio Del Prete, Ciro Caruso
  • COLORING SUBSTANCE FOR DIAGNOSTIC OPHTALMOLOGIC USE
    Publication number: 20140371569
    Abstract: The present invention relates to a substance selected from the group consisting of riboflavin, its esters, salts and hydrates thereof, for use in an ophthalmic diagnostic method. In preferred aspects of the invention, the riboflavin is applied into the eye as part of a solution having a concentration from about 0.01 and 0.5% riboflavin or acceptable salt, ester, hydrate thereof.
    Type: Application
    Filed: September 3, 2014
    Publication date: December 18, 2014
    Inventors: Ciro CARUSO, Salvatore TROISI
  • OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE
    Publication number: 20120121567
    Abstract: An ophthalmic solution containing riboflavin and at least a compound chosen in the group composed of essential and conditionally essential amino acids, coenzyme Q, L-proline, glycine, lysine hydrochloride, L-leucine, L-arginine and compounds intended to stimulate the production of metalloproteinase MMP9 for the protection of internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique.
    Type: Application
    Filed: July 23, 2010
    Publication date: May 17, 2012
    Inventors: Salvatore Troisi, Antonio Del Prete, Ciro Caruso